Related Experiment Video
Updated: May 11, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Dietary index for gut microbiota (DI-GM) and irritable bowel syndrome: a case-control study
Yatian Wang1, Guoshan Zhang1, Shen Lin2
1Department of Gastroenterology, Central Hospital Affiliated to Shandong First Medical University, No.105, Jiefang Road, Lixia District, Jinan, Shandong, 250013, China.
Abstract:
This study investigated whether the Dietary Index for Gut Microbiota (DI-GM), a measure of diet quality for gut health, is associated with IBS risk, and symptom severity, inflammation. A case-control study included 350 adults (175 IBS patients per Rome IV and 175 matched controls). Dietary intake was assessed using a validated food frequency questionnaire to calculate DI-GM scores. Irritable Bowel Syndrome severity and quality of life were measured via the Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS), Irritable Bowel Syndrome Extended Symptom Severity Scale (IBS-EISSS), and Irritable Bowel Syndrome Quality of Life questionnaire (IBS-QOL). Serum inflammatory markers-including C-reactive protein (CRP), lipopolysaccharide (LPS), zonulin, tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and brain-derived neurotrophic factor (BDNF)-were quantified using ELISA. IBS patients had significantly lower DI-GM scores than controls (7.69 ± 3.12 vs. 12.15 ± 2.60; p < 0.001). Participants in the highest DI-GM tertile showed significantly lower zonulin (31.33 ± 0.58 vs. 56.01 ± 22.49 ng/mL; p < 0.001), LPS (1.03 ± 0.30 vs. 1.84 ± 0.47 EU/mL; p < 0.001), and CRP (3.10 ± 0.03 vs. 5.53 ± 1.41 mg/L; p < 0.001). Higher DI-GM scores were associated with lower psychological scores and IBS symptom severity (all p < 0.001). Importantly, IBS symptom severity showed strong positive correlations with inflammatory markers, suggesting that symptom severity may drive dietary modifications and inflammatory responses. Logistic regression indicated that individuals in the highest DI-GM tertile had substantially lower odds of IBS compared to the lowest tertile. Higher DI-GM scores were associated with lower IBS odds and favorable profiles. However, strong correlations between symptom severity and inflammation suggest reverse causality-symptoms may drive dietary changes rather than diet determining disease. Due to the cross-sectional design, causal inference is not permitted, and prospective studies are required.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Functions of the Gut Microbiota
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

